Commerzbank posts flat net profit in second quarter, helped by low taxes
Germany’s Commerzbank on Wednesday posted net profit in the second quarter that was little changed from a year ago, helped by low taxes, but said...
COMAC pushes back C919 jet’s China certification target to 2021
Commercial Aircraft Corp of China (COMAC) aims to obtain Chinese certification for its C919 jet in 2021, the company said, marking a delay from a...
COMAC aims to obtain C919 jet’s China certification in 2021: state media
Commercial Aircraft Corp of China (COMAC) aims to obtain certification from China for its narrowbody C919 jet in 2021, state media reported on Wednesday, citing...
U.N. members sign mediation convention to settle trade disputes
Members of the United Nations on Wednesday signed the Singapore Convention on Mediation, an agreement it hopes will make it easier to settle cross-border commercial...
Oil prices steady, U.S.-China trade dispute remains in focus
Oil prices steadied on Wednesday after falling at the start of the session, with the potential for damage to the global economy and fuel demand...
New York retail icon Barneys files for bankruptcy
Barneys New York Inc filed for bankruptcy protection on Tuesday and put itself up for sale, pushed to the brink by falling revenue and soaring...
Fragile calm returns to stock markets as yuan steadies
Asian shares steadied slightly on Wednesday as investors caught their breath from a searing week-long selloff, with steps taken by Chinese authorities to contain a...
Twitter says it may have used user data for ads without permission
Twitter Inc said on Tuesday that it may have used data for personalized ads without a user’s permission due to issues with the microblogging website’s...
Walmart says Mexico same-store sales rise 2.2% in July
Walmart de Mexico, Mexico’s biggest retailer, said on Tuesday that sales at stores open for more than a year in Mexico rose by 2.2% in...
U.S. FDA says some data testing Novartis’ $2 million gene therapy was manipulated
The U.S. Food and Drug Administration said on Tuesday that some data from early testing of Novartis’ more than $2 million gene therapy Zolgensma was...